{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:32:24Z","timestamp":1789086744223,"version":"build-2803163510"},"reference-count":33,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet. World"],"published-print":{"date-parts":[[2026,6,30]]},"abstract":"<jats:p>Background and Aim: Myxomatous mitral valve disease (MMVD) is the most common cardiac disorder in dogs and is frequently associated with progressive cardiac remodeling and pulmonary hypertension (PH). Increasing evidence suggests that systemic inflammation contributes to disease progression; however, the clinical relevance of inflammatory biomarkers in relation to cardiac structural changes and outcomes remains incompletely understood. This study aimed to evaluate the associations between C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), cardiac remodeling indices, PH, and survival outcomes in dogs with MMVD. \n\nMaterials and Methods: A retrospective cohort study was conducted using medical records of 94 client-owned dogs diagnosed with MMVD between 2023 and 2025. Dogs were classified according to the American College of Veterinary Internal Medicine (ACVIM) stages (B1\u2013D). Echocardiographic parameters, including left atrial (LA) volume, LA\/Ao ratio, and left ventricular internal diameter, were assessed alongside PH status determined by tricuspid regurgitation velocity. Hematologic parameters and serum CRP concentrations were analyzed. Correlation, regression, receiver operating characteristic (ROC), and survival analyses were performed to determine associations and prognostic value. \n\nResults: LA enlargement was observed in 84.0% of dogs and increased with disease severity. CRP and NLR showed weak but statistically significant positive correlations with indexed LA volume (CRP: r = 0.31, p &lt; 0.01; NLR: r = 0.29, p &lt; 0.05). Neither biomarker demonstrated a significant association with PH. Indexed LA volume, rather than inflammatory biomarkers, was more strongly associated with echocardiographic indicators of PH risk. CRP exhibited moderate diagnostic performance for PH (area under the curve = 0.7517, p &lt; 0.001), whereas NLR showed poor discrimination. Survival analysis revealed that dogs with elevated CRP levels and concurrent PH had significantly reduced survival probabilities. Although NLR increased with disease progression, its prognostic utility remained limited. \n\nConclusion: Systemic inflammatory biomarkers, particularly CRP, are modestly associated with cardiac remodeling and survival in dogs with MMVD but are not reliable predictors of PH. Echocardiographic indices, especially LA remodeling, remain superior indicators of disease severity and PH risk. While CRP may provide adjunctive prognostic value, its clinical application should be interpreted cautiously alongside established imaging parameters. \n\nKeywords: cardiac remodeling, c-reactive protein, dog, myxomatous mitral valve disease, neutrophil-to-lymphocyte ratio, pulmonary hypertension, survival analysis, veterinary cardiology.<\/jats:p>","DOI":"10.14202\/vetworld.2026.2279-2292","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:31:38Z","timestamp":1780702298000},"page":"2279","update-policy":"https:\/\/doi.org\/10.14202\/vetworld.2022.policies","source":"Crossref","is-referenced-by-count":1,"title":["Associations of C-reactive protein and neutrophil-to-lymphocyte ratio with cardiac remodeling, pulmonary hypertension, and survival outcomes in dogs with myxomatous mitral valve disease"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4244-6955","authenticated-orcid":false,"given":"Suchada","family":"Huttayananont","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05gzceg21","id-type":"ROR","asserted-by":"publisher"}],"name":"Kasetsart University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3734-1357","authenticated-orcid":false,"given":"Chattida","family":"Panprom","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05gzceg21","id-type":"ROR","asserted-by":"publisher"}],"name":"Kasetsart University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0679-1121","authenticated-orcid":false,"given":"Sitha","family":"Sarikan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/039mhfq69","id-type":"ROR","asserted-by":"publisher"}],"name":"Bangkok Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1902-4895","authenticated-orcid":false,"given":"Ratiporn","family":"Tantisak","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/039mhfq69","id-type":"ROR","asserted-by":"publisher"}],"name":"Bangkok Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornnicha","family":"Saringkarisate","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/039mhfq69","id-type":"ROR","asserted-by":"publisher"}],"name":"Bangkok Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-937X","authenticated-orcid":false,"given":"Soontaree","family":"Petchdee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03y12yp46","id-type":"ROR","asserted-by":"publisher"}],"name":"Nakhon Pathom Rajabhat University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5308","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"ref0","unstructured":"1. Atkins C.E., H\u00e4ggstr\u00f6m J. Epidemiology and pathophysiology of chronic valvular heart disease in dogs. J VetCardiol. 2009;11:S93\u2013S97."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Borgarelli M., Buchanan J.W. Historical review, epidemiology and natural history of degenerative mitral valvedisease. J Vet Cardiol. 2012;14:93\u2013101.","DOI":"10.1016\/j.jvc.2012.01.011"},{"key":"ref2","unstructured":"3. Johnson L. Diagnosis of pulmonary hypertension in dogs: Echocardiography and beyond. Vet. Clin. North AmSmall Anim Pract. 2010;40:839\u2013852."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. Visser L.C., Im M.K., Johnson L.R., Stern J.A. Diagnostic value of pulmonary artery\/aorta ratio determined byechocardiography in dogs with pulmonary hypertension. J Vet Intern Med. 2016;30:543\u2013550.","DOI":"10.1111\/jvim.13911"},{"key":"ref4","unstructured":"5. Kellihan H.B., MacDonald K.A. Echocardiographic assessment of pulmonary artery pressure in dogs:Evaluation of a ratio of pulmonary artery to aortic diameter. J Vet Intern Med. 2010;24:1429\u20131433."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Chalermpromma P., Surachetpong S.D. Indicators for pulmonary hypertension in dogs with degenerativemitral valve disease. Vet World. 2023;16(12):2515\u20132520.","DOI":"10.14202\/vetworld.2023.2515-2520"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Mann D.L. Innate immunity and the failing heart: The cytokine hypothesis revisited. Circ Res. 2015;116:1254\u20131268.","DOI":"10.1161\/CIRCRESAHA.116.302317"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Bhat T., Teli S., Rijal J., Bhat H., Raza M., Khoueiry G., Meghani M., Akhtar M., Costantino T. Neutrophil-to-lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther. 2013;11:55\u201359.","DOI":"10.1586\/erc.12.159"},{"key":"ref8","unstructured":"9. Uemura Y., Shibata R., Takemoto K., Uchikawa T., Kawasoe T., Kanemura N., Ueda S., Yuasa D., Kondo M.,Matsuo K., et al. Prognostic impact of neutrophil-to-lymphocyte ratio on long-term outcomes in patientswith chronic heart failure. Int Heart J. 2014;55:290\u2013296."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. DeProspero D.J., Hess R.S., Silverstein D.C. Neutrophil-to-lymphocyte ratio is increased in dogs with acutecongestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heartmurmurs and healthy controls. JAVMA. 2023;261(11):1\u20138.","DOI":"10.2460\/javma.23.03.0131"},{"key":"ref10","unstructured":"11. Chang D., Yang M.P., Kang B.T. Severity of myxomatous mitral valve disease in dogs may be predicted usingneutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio. Am. J. Vet. Res. 2023;84."},{"key":"ref11","unstructured":"12. Ayd\u0131n A., Y\u0131lmaz R., Uysal A., Ko\u00e7ak H. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio indogs with various degrees of myxomatous mitral valve disease. Egypt J Vet Sci. 2023;64:151\u2013159."},{"key":"ref12","unstructured":"13. Tarnow I., Falk T., Tidholm A., Martinussen T., Olsen L.H., Pedersen H.D., H\u00e4ggstr\u00f6m J., Kamstrup T.S.,Kjelgaard-Hansen M. Serum C-reactive protein concentration in dogs with congestive heart failure caused bymyxomatous mitral valve disease. Vet J. 2007;173:601\u2013606."},{"key":"ref13","unstructured":"14. Zois N.E., Olsen L.H., Sexton J., Rasmussen C.E., Falk T., Kanters J.K., Moesgaard S.G., Pedersen H.D.,H\u00e4ggstr\u00f6m J., H\u00f6glund K., et al. Circulating cytokine concentrations in dogs with different degrees ofmyxomatous mitral valve disease. Vet J. 2011;187:186\u2013191."},{"key":"ref14","unstructured":"15. Oyama M.A., Sisson D.D., Solter P.F. Cardiac troponin I concentration in dogs with cardiac disease. J Vet InternMed. 2007;21:968\u2013975."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Dal-Bianco J.P., Beaudoin J., Handschumacher M.D., Levine R.A. Basic mechanisms of mitral regurgitation.Can J Cardiol. 2014;30:971\u2013981.","DOI":"10.1016\/j.cjca.2014.06.022"},{"key":"ref16","unstructured":"17. Chatterjee N.A., Murphy S.P., Mallick A., et al. CRP and risk of atrial fibrillation: The Framingham study. AmHeart J. 2016;171:63\u201370."},{"key":"ref17","unstructured":"18. Pasmans M., Smets P., Van den Broeck W., et al. C-reactive protein as a marker for inflammation in dogs withMMVD. Vet J. 2015;203:92\u201397."},{"key":"ref18","unstructured":"19. Zafrir B., Salman N., Shacham Y., et al. Neutrophil-to-lymphocyte ratio and CRP in predicting long-termoutcomes in heart failure patients. Clin Res Cardiol. 2016;105:581\u2013588."},{"key":"ref19","unstructured":"20. Visser L.C., Scansen B.A., Schober K.E., Bonagura J.D. Echocardiographic assessment of left atrial size andfunction in dogs. J Vet Cardiol. 2019;21:1\u201317."},{"key":"ref20","unstructured":"21. Kellihan H.B., Stepien R.L. Clinical characterization of canine pulmonary hypertension: 125 cases (2001\u20132011). J Vet Cardiol. 2012;14:61\u201370."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22. Cornell C.C., Kittleson M.D., Della Torre P., H\u00e4ggstr\u00f6m J., Lombard C.W., Pedersen H.D., Vollmar A., Wey A.Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004;18(3):311\u2013321.","DOI":"10.1111\/j.1939-1676.2004.tb02551.x"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23. Wallis C.V., Soltero-Rivera M., Harvey C., Reynolds R.M., Carvell-Miller L.J., Colyer A., McKee T.S., Mills T.,Bergman P.J., Watson P., Holcombe L.J. Real-world diagnostic potential of bacterial biomarkers of canineperiodontitis. Front Vet Sci. 2024;11:1377119.","DOI":"10.3389\/fvets.2024.1377119"},{"key":"ref23","unstructured":"24. C\u00f4t\u00e9 E., Ettinger S.J., Sisson D.D. Ettinger\u2019s textbook of veterinary internal medicine: Diseases of the dog andthe cat. 8th ed. Elsevier, St. Louis, MO, USA. 2017."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25. Keene B.W., Atkins C.E., Bonagura J.D., Fox P.R., H\u00e4ggstr\u00f6m J., Luis Fuentes V., Oyama M.A., Rush J.E., StepienR., Uechi M. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valvedisease in dogs. J Vet Intern Med. 2019;33(3):1127\u20131140.","DOI":"10.1111\/jvim.15488"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26. Reinero C., Visser L.C., Kellihan H.B., Masseau I., Rozanski E., Clercx C., Williams K., Abbott J., Borgarelli M.,Scansen B.A. ACVIM consensus statement guidelines for the diagnosis, classification, treatment, andmonitoring of pulmonary hypertension in dogs. J Vet Intern Med. 2020;34(2):549\u2013573.","DOI":"10.1111\/jvim.15725"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27. Re\u0161etar Maslov D., Farka\u0161 V., Rubi\u0107 I., Kule\u0161 J., Beleti\u0107 A., Beer Ljubi\u0107 B., \u0160mit I., Mrljak V., Torti M. Serumproteomic profiles reflect the stages of myxomatous mitral valve disease in dogs. Int J Mol Sci.2023;24(8):7142.","DOI":"10.3390\/ijms24087142"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28. Goggs R. The use of biomarkers to track and treat critical illness. Vet Clin North Am Small Anim Pract.2025;55(3):459\u2013482.","DOI":"10.1016\/j.cvsm.2025.01.010"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29. Ogawa M., Ogi H., Miyakawa H., Hsu H.H., Miyagawa Y., Takemura N. Evaluation of the association betweenelectrocardiogram parameters and left cardiac remodeling in dogs with myxomatous mitral valve disease.Vet World. 2022;15(8):2072\u20132083.","DOI":"10.14202\/vetworld.2022.2072-2083"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30. Zhang J.L., Yang R., Zhu Y., Shao Y., Ji Y., Wang F.F. Association between the neutrophil-to-lymphocyte ratioand risk of in-hospital heart failure and arrhythmia in patients with acute myocardial infarction. FrontCardiovasc Med. 2023;10:1275713.","DOI":"10.3389\/fcvm.2023.1275713"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31. Tangmahakul N., Rungsipipat A., Surachetpong S.D. Investigation of pulmonary artery and circulatingendothelin-1 expression in dogs with pulmonary hypertension secondary to myxomatous mitral valvedisease. Vet World. 2024;17(9):2144\u20132151.","DOI":"10.14202\/vetworld.2024.2144-2151"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32. Reimann M.J., Ljungvall I., Hillstr\u00f6m A., M\u00f8ller J.E., Hagman R., Falk T., H\u00f6glund K., H\u00e4ggstr\u00f6m J., Olsen L.H.Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatousmitral valve disease. Vet J. 2016;209:113\u2013118.","DOI":"10.1016\/j.tvjl.2015.12.006"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33. Domanjko Petri\u010d A., Lukman T., Verk B., Nemec Svete A. Systemic inflammation in dogs with advanced-stageheart failure. Acta Vet Scand. 2018;60(1):20.","DOI":"10.1186\/s13028-018-0372-x"}],"container-title":["Veterinary World"],"original-title":[],"link":[{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/June-2026\/2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:32:00Z","timestamp":1780702320000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryworld.org\/Vol.19\/June-2026\/2.php"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":33,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2026.2279-2292","relation":{},"ISSN":["0972-8988","2231-0916"],"issn-type":[{"value":"0972-8988","type":"print"},{"value":"2231-0916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"2"}}